Provided by Tiger Trade Technology Pte. Ltd.

ResMed

231.52
+3.081.35%
Post-market: 231.520.00000.00%19:30 EDT
Volume:1.73M
Turnover:399.65M
Market Cap:33.40B
PE:22.20
High:234.14
Open:229.44
Low:228.54
Close:228.44
52wk High:293.81
52wk Low:180.27
Shares:144.25M
Float Shares:143.49M
Volume Ratio:1.34
T/O Rate:1.20%
Dividend:2.40
Dividend Rate:1.04%
EPS(TTM):10.43
EPS(LYR):10.43
ROE:24.27%
ROA:14.00%
PB:5.07
PE(LYR):22.20

Loading ...

RBC Capital Adjusts PT on ResMed to $244 From $234, Maintains Sector Perform Rating

MT Newswires Live
·
Aug 07

ResMed price target raised to $244 from $234 at RBC Capital

TIPRANKS
·
Aug 07

ResMed price target lowered to $213 from $217 at Baird

TIPRANKS
·
Aug 07

ResMed price target lowered to $215 from $225 at Wells Fargo

TIPRANKS
·
Aug 07

Resmed Shares Down 8.7% Premarket After Q4 Results

THOMSON REUTERS
·
Aug 07

Stock Track | ResMed Plunges 8.78% in 24-Hour Trading as Revenue Growth Deceleration Overshadows Q4 Earnings Beat

Stock Track
·
Aug 07

Movement Alert|ResMed Falls 8.41% in Pre-Market Trading, Earnings Beat Expectations but Revenue Growth Deceleration Sparks Concern

Market Focus
·
Aug 07

Resmed Inc. : RBC Raises Target Price to $244 from $234

THOMSON REUTERS
·
Aug 07

Resmed Inc. : Piper Sandler Cuts Target Price to $225 from $233

THOMSON REUTERS
·
Aug 07

Stock Track | ResMed Plunges 6.07% in 24-Hour Trading as Revenue Growth Deceleration Overshadows Q4 Earnings Beat

Stock Track
·
Aug 07

Movement Alert|ResMed Declines 6.15% Overnight, Earnings Beat but Revenue Growth Slowdown Sparks Concerns

Market Focus
·
Aug 07

Deferral of Conversions Between Australian and US Registers-RMD.N

Reuters
·
Aug 07

144 Report of Proposed Sale of Securities-RMD.N

Reuters
·
Aug 07

Resmed Q4 FY2026 Earnings: Revenue Rises as Safety Costs Weigh on GAAP Margins

TradingKey
·
Aug 07

ResMed Fiscal Q4 Non-GAAP Earnings, Revenue Up

MT Newswires Live
·
Aug 07

ResMed Raises Quarterly Dividend, Reports Higher 4Q Revenue, Profit

Dow Jones
·
Aug 07

ResMed Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

ResMed Posts Fiscal Q4 Non-GAAP EPS of $2.95, Revenue of $1.46 Billion

MT Newswires Live
·
Aug 07

Stock Track | ResMed Plunges 6.83% in After-Hours Trading as Revenue Growth Deceleration Overshadows Q4 Earnings Beat

Stock Track
·
Aug 07

Movement Alert|ResMed Falls 5.03% in After-Hours Trading, Earnings Beat but Growth Deceleration Raises Concerns

Market Focus
·
Aug 07